Cargando…
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome
BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343541/ https://www.ncbi.nlm.nih.gov/pubmed/28274246 http://dx.doi.org/10.1186/s13054-017-1625-1 |
_version_ | 1782513383514308608 |
---|---|
author | Antonakos, Nikolaos Tsaganos, Thomas Oberle, Volker Tsangaris, Iraklis Lada, Malvina Pistiki, Aikaterini Machairas, Nikolaos Souli, Maria Bauer, Michael Giamarellos-Bourboulis, Evangelos J. |
author_facet | Antonakos, Nikolaos Tsaganos, Thomas Oberle, Volker Tsangaris, Iraklis Lada, Malvina Pistiki, Aikaterini Machairas, Nikolaos Souli, Maria Bauer, Michael Giamarellos-Bourboulis, Evangelos J. |
author_sort | Antonakos, Nikolaos |
collection | PubMed |
description | BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononuclear cells (PBMCs) were isolated within the first 24 h from the onset of systemic inflammatory response syndrome in 95 patients with microbiologically confirmed or clinically suspected gram-negative infections. Isolation was repeated on days 3, 7 and 10. PBMCs were stimulated for cytokine production. The study endpoints were the differences between survivors and non-survivors, the persistence of immunosuppression, and determination of admission clinical signs that can lead to early identification of the likelihood of immunosuppression. RESULTS: PBMCs of survivors produced significantly greater concentrations of tumour necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, IL-10, interferon-γ and granulocyte-macrophage colony-stimulating factor after day 3. Using ROC analysis, we found that TNF-α production less than 250 pg/ml after lipopolysaccharide stimulation on day 3 could discriminate patients from healthy control subjects; this was associated with a 5.18 OR of having an unfavourable outcome (p = 0.046). This trait persisted as long as day 10. Logistic regression analysis showed that cardiovascular failure on admission was the only independent predictor of defective TNF-α production on day 3. CONCLUSIONS: Defective TNF-α production is a major trait of sepsis-induced immunosuppression. It is associated with significant risk for unfavourable outcome and persists until day 10. Cardiovascular failure on admission is predictive of defective TNF-α production during follow-up. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01223690. Registered on 18 October 2010. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1625-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5343541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53435412017-03-10 Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome Antonakos, Nikolaos Tsaganos, Thomas Oberle, Volker Tsangaris, Iraklis Lada, Malvina Pistiki, Aikaterini Machairas, Nikolaos Souli, Maria Bauer, Michael Giamarellos-Bourboulis, Evangelos J. Crit Care Research BACKGROUND: Failure of circulating monocytes for adequate cytokine production is a trait of sepsis-induced immunosuppression; however, its duration and association with final outcome are poorly understood. METHODS: We conducted a substudy of a large randomised clinical trial. Peripheral blood mononuclear cells (PBMCs) were isolated within the first 24 h from the onset of systemic inflammatory response syndrome in 95 patients with microbiologically confirmed or clinically suspected gram-negative infections. Isolation was repeated on days 3, 7 and 10. PBMCs were stimulated for cytokine production. The study endpoints were the differences between survivors and non-survivors, the persistence of immunosuppression, and determination of admission clinical signs that can lead to early identification of the likelihood of immunosuppression. RESULTS: PBMCs of survivors produced significantly greater concentrations of tumour necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, IL-10, interferon-γ and granulocyte-macrophage colony-stimulating factor after day 3. Using ROC analysis, we found that TNF-α production less than 250 pg/ml after lipopolysaccharide stimulation on day 3 could discriminate patients from healthy control subjects; this was associated with a 5.18 OR of having an unfavourable outcome (p = 0.046). This trait persisted as long as day 10. Logistic regression analysis showed that cardiovascular failure on admission was the only independent predictor of defective TNF-α production on day 3. CONCLUSIONS: Defective TNF-α production is a major trait of sepsis-induced immunosuppression. It is associated with significant risk for unfavourable outcome and persists until day 10. Cardiovascular failure on admission is predictive of defective TNF-α production during follow-up. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01223690. Registered on 18 October 2010. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1625-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-09 /pmc/articles/PMC5343541/ /pubmed/28274246 http://dx.doi.org/10.1186/s13054-017-1625-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Antonakos, Nikolaos Tsaganos, Thomas Oberle, Volker Tsangaris, Iraklis Lada, Malvina Pistiki, Aikaterini Machairas, Nikolaos Souli, Maria Bauer, Michael Giamarellos-Bourboulis, Evangelos J. Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title | Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title_full | Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title_fullStr | Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title_full_unstemmed | Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title_short | Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
title_sort | decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343541/ https://www.ncbi.nlm.nih.gov/pubmed/28274246 http://dx.doi.org/10.1186/s13054-017-1625-1 |
work_keys_str_mv | AT antonakosnikolaos decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT tsaganosthomas decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT oberlevolker decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT tsangarisiraklis decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT ladamalvina decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT pistikiaikaterini decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT machairasnikolaos decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT soulimaria decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT bauermichael decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome AT giamarellosbourboulisevangelosj decreasedcytokineproductionbymononuclearcellsafterseveregramnegativeinfectionsearlyclinicalsignsandassociationwithfinaloutcome |